SUBSCRIBERS
Best World to invest in A*Star startup with an eye on stem cell-based products
Published Mon, Jan 14, 2019 · 09:50 PM
Singapore
BEST World International is investing in A*Star spinoff Celligenics as it seeks to leverage on synergies with its own business in the health and wellness sector.
In a filing with the Singapore Exchange on Monday, it said that it had entered into a share subscription agreement (SSA) with Celligenics.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Chevron CEO expects ExxonMobil arbitration resolved in coming months
Paramount replaces CEO with trio as it talks merger with Skydance
MicroStrategy posts loss on impairment charge, revenue declines
JPMorgan looks to fend off Goldman and other private credit for US$1 billion
China’s top airlines improve balance sheet in Q1; outlook positive for May Day
Stablecoin issuer Tether invests US$200 million in brain-computer interface company